.svg){kind=small}
Where to Buy
Foy is stocked at 116 licensed dispensaries across New York, with the deepest coverage in New York, Brooklyn, Queens, Binghamton, and Buffalo. Search by ZIP code or city below to find the closest one.
Market Insights Snapshot
Edible held 100.0% of Foy’s mix in September 2026, with category sales up 4.16% year over year and 11.45% month over month, while the brand’s average price decreased 2.22% YoY alongside a 3.90% YoY lift in total brand sales. Within Edible, average price at $24.16 paired with a double-digit MoM sales gain of 11.45% implies that September 2026 volume expanded faster than price reductions, and the 4.16% YoY growth concentrated entirely in Edible indicates single-category dependency rather than diversification.
In New York Edible, Foy’s rank at 16 and the 11.45% MoM upswing point to near-term share capture potential if price elasticity continues to work at a 2.22% YoY discount, whereas the 4.16% YoY pace suggests limited runway if category growth cools. This pattern implies Foy’s positioning leans on value-led Edible volume in September 2026, so future rank movement will hinge on sustaining double-digit MoM velocity while converting the single-category exposure into durable share gains.
Competitive Landscape
Foy sits at #16 in NY Edible for September 2026, slipping 1 position from #15 year over year and easing 1 rank from #15 in June 2026, while still trailing its peak of #14 reached in July 2025; meanwhile, Camino climbed from #2 to #1 and Wyld rose from #3 to #2 with 13.98% YoY sales growth, contrasting with Off Hours falling from #1 to #3 on a -28.14% YoY decline, which indicates Foy’s flat-to-down rank drift amid both upward mobility at the top and volatility just ahead implies share is getting squeezed unless Foy converts stability into upward movement before fourth-quarter resets.
Notable Products
CBD/THC/CBC 1:1:1 Good Mood Peach Chews 4-Pack (20mg THC, 20mg CBD, 20mg CBC) posted the largest month-over-month move in September 2026 with +192.99% and climbed into rank 6, while Strawberry Gummy 20-Pack (100mg) fell -22.24% and slid to rank 7; this divergence indicates trial is concentrating in functional micro-pack formats as legacy generic gummies contract. CBD/THC/CBN 1:1:1 Night Time Strawberry Adaptogen Chews 20-Pack (100mg THC, 100mg CBD, 100mg CBN) held rank 1 with +23.03% and an estimated $142,528, and CBD/THC/CBC 1:1:1 Good Mood Peach Chews 20-Pack (100mg CBD, 100mg THC, 100mg CBC) rose +15.04% at rank 3, meaning two of the top three are 20-packs anchored in multi-cannabinoid functional positioning. With six of the top eight SKUs in September 2026 being functional 1:1:1 cannabinoid blends across Night Time, Daytime, and Good Mood, the mix points to Foy leaning into form-factor variety (4-packs and 20-packs) to build laddered entry and repeat around effect-driven occasions.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
